Key statistics
As of last trade, Xenon Pharmaceuticals Inc (XP0:DEU) traded at 36.00, 40.63% above the 52 week low of 25.60 set on Nov 16, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 36.40 |
---|---|
High | 36.80 |
Low | 35.40 |
Bid | 36.00 |
Offer | 37.40 |
Previous close | 35.80 |
Average volume | 23.33 |
---|---|
Shares outstanding | 75.76m |
Free float | 74.90m |
P/E (TTM) | -- |
Market cap | 3.09bn USD |
EPS (TTM) | -2.74 USD |
Data delayed at least 15 minutes, as of Sep 19 2024.
More ▼
Announcements
- Xenon Showcases Azetukalner Data at 15th European Epilepsy Congress
- Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating Officer
- Xenon Reports Q2 2024 Financial Results and Business Update
- Xenon to Report Q2 2024 Financial Results on August 8, 2024
- Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
- Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting
- Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
- Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024
- Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference
- Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update
More ▼